Publication:
Comparison of Clinical Outcomes Between Surgical Gastrostomy and Percutaneous Endoscopic Gastrostomy with Introducer Technique in Patients with Upper Aerodigestive Malignancies: A Single-Center Analysis

dc.contributor.authorArunchai Changen_US
dc.contributor.authorChomduan Watcharamonen_US
dc.contributor.authorAttapon Rattanasupaen_US
dc.contributor.authorKittikarn Thongsonkleeben_US
dc.contributor.authorBunlue Chowdoken_US
dc.contributor.authorAraya Khaimooken_US
dc.contributor.authorBancha Ovartlarnpornen_US
dc.contributor.authorVarayu Prachayakulen_US
dc.contributor.otherHatyai Hospitalen_US
dc.contributor.otherFaculty of Medicine, Siriraj Hospital, Mahidol Universityen_US
dc.contributor.otherPrince of Songkla Universityen_US
dc.date.accessioned2020-06-02T05:27:30Z
dc.date.available2020-06-02T05:27:30Z
dc.date.issued2020-01-01en_US
dc.description.abstract© 2020, Société Internationale de Chirurgie. Background: Conventional percutaneous endoscopic gastrostomy (PEG) in patients with upper aerodigestive malignancies inevitably carries a risk of stomal metastasis that could be avoided by the direct insertion of the gastrostomy tube through the abdomen. This study compared the efficacy and safety between surgical gastrostomy (SG) and Introducer PEG in patients with upper aerodigestive malignancies. Methods: We retrospectively reviewed patients with upper aerodigestive malignancies undergoing SG or Introducer PEG. Procedure data, postprocedural clinical outcomes and 30-day mortality were assessed. Results: In total, 99 patients were feasible to analysis: 53 were in the SG group, and 46 were in the Introducer PEG group. The SG group had a higher incidence of (in-hospital) major complications [28.3% VS 4.3%, p = 0.002], a longer procedure duration [52.02 ± 21.30 VS 21.46 ± 8.22 min, p < 0.001], higher pain scores at 24 h [median (interquartile range, IQR); 5(3–8) VS 1(0–5), p < 0.001] and longer length of hospitalization (LOH) [median (IQR); 5(4–6) days VS 3(2–4) days, p < 0.001)]. In-hospital (3.8% VS 0%, p = 0.493) and 30-day mortality (17.0% VS 13.0%, p = 0.586) were not different between the two groups. In univariate analysis, high BMI, anemia (hemoglobin <11 g/dL), normal nutritional status (serum albumin >3 g/dL) and procedural type were found to be predicting factors for complications. Procedural type (Introducer PEG) was an independent factor for major complications in multivariate analysis [OR = 0.12, 95% CI 0.02–0.61, p= 0.011]. Conclusions: In patients with upper aerodigestive malignancies, Introducer PEG was associated with lower rate of (in-hospital) major complications, faster operative time, lower pain scores and shorter LOH. Clinical trials registry number: TCTR20181220004.en_US
dc.identifier.citationWorld Journal of Surgery. (2020)en_US
dc.identifier.doi10.1007/s00268-020-05532-zen_US
dc.identifier.issn14322323en_US
dc.identifier.issn03642313en_US
dc.identifier.other2-s2.0-85083970696en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/56327
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85083970696&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleComparison of Clinical Outcomes Between Surgical Gastrostomy and Percutaneous Endoscopic Gastrostomy with Introducer Technique in Patients with Upper Aerodigestive Malignancies: A Single-Center Analysisen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85083970696&origin=inwarden_US

Files

Collections